News
With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...
If your soul needs a tune-up and your body could use a little love, too, Desert Healing in Kanab just became your go-to ...
Nearly two in three people with fatty liver disease lost some of the liver fat and inflammation after using semaglutide 2.4 ...
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy ...
Consumers looking to start the popular weight loss drug Wegovy but lacking insurance coverage will soon have a new option.
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
The companies, which have at times had an adversarial relationship, also said they would develop a roadmap to continue their ...
A federal judge in Texas handed Novo Nordisk (NVO) a big win late Thursday in its battle against cheaper versions of its ...
Gavin Newsom’s administration has reported that half of the doubling in Medi-Cal costs over the past six years has been from ...
Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results